Healthcare Access

People Served: 380 million people across 15 SADC countries gain access to high-quality, affordable essential medicines.

Medicine Availability: 7 WHO Essential Medicines manufactured locally, reducing stock-outs and improving healthcare system reliability.

Cost Reduction: 20-30% lower prices compared to imported medicines, improving affordability for patients and healthcare systems.

Supply Chain Resilience: Local manufacturing reduces dependence on vulnerable international supply chains, ensuring consistent medicine availability.

Economic Impact

Jobs Created: 150+ direct pharmaceutical manufacturing jobs (target: 40% women) plus 300+ indirect jobs in supply chain, logistics, and distribution.

Import Substitution: $50 million+ in pharmaceutical imports replaced by local production by Year 5, keeping capital within SADC economies.

Technology Transfer: WHO GMP pharmaceutical manufacturing expertise and skills development in Mozambique and SADC region.

Local Value Chain: Developing local suppliers for packaging, logistics, and ancillary services, creating multiplier effects across the economy.

Social Impact

Skills Development: Comprehensive pharmaceutical manufacturing training programs, WHO GMP certification for local workforce, career pathways in biotechnology.

Gender Equality: 40% women employment target across all levels with leadership development programs and fair wages.

Community Development: Support for healthcare infrastructure in Nacala region and education partnerships with local institutions.

Sustainable Development Goals (SDGs)

Timeline to Impact